New derivatives of the 1,3,4-thiadiazole scaffold were synthesized and evaluated for their cytotoxic effects on breast (MCF-7), hepatic (HepG-2), and colorectal (HCT-116) carcinomas. The most active compounds (7, 8, 15, and 16) exhibited substantial, broad-spectrum anticancer efficacy, with IC50 values ranging from 1.5...
A. Belal, M. Abourehab, Reem I. Alsantali et al.· RSC Advances· 0 citations
As a non-steroidal aromatase inhibitor, letrozole is primarily used for treating estrogen-dependent breast cancer (BC). However, the long-term use of letrozole is limited due to severe adverse effects, including increased risks of cardiovascular disease and osteoporosis. A new bis-triazole compound derived from letrozo...
Wael A. A. Fadaly, Seif E. Ahmed, Fahad H. Baali et al.· Journal of Pharmacy and Scie...· 0 citations
These findings establish the nasal NLU formulation as a promising therapeutic platform to mitigate doxorubicin-induced cardiotoxicity and exhibit superior cardioprotective and antioxidant performance over the oral NFP.
H. Farouk, F. A. Abo El-Ela, Fahad H. Baali et al.· Journal of drug targeting (P...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.